Navigation Links
DSM Announces SafeBridge(R) Potent Compound Safety Certification
Date:8/5/2009

and finished dose form manufacturing of solids, semi-solids, and scheduled drugs, aseptic liquid and lyophilized products. More information: www.dsmpharmaceuticals.com

Royal DSM N.V. - The Life Sciences and Materials Sciences Company

Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM's products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrics and electronics, life protection and housing. DSM has annual sales of almost EUR 8.8 billion and employs some 23,000 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com

SafeBridge Consultants, Inc.

The premier occupational health and safety consulting firm to the pharmaceutical, biotechnology and fine chemical industry with offices in Mountain View, CA, New York, NY and Liverpool, UK. SafeBridge has provided the Potent Compound Safety Triangle(TM) of services in industrial hygiene, occupational toxicology and industrial hygiene analytical chemistry to over 400 business units worldwide and is a leader in recognizing, evaluating and controlling exposures to potent active pharmaceutical ingredients and products. More information www.safebridge.com

For further information please contact: 

    DSM Pharmaceutical Products       SafeBridge Consultants, Inc.
    David Linn                        John P. Farris, CIH
'/>"/>
SOURCE  DSM Pharmaceutical Products
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related medicine news :

1. Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million
2. ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomycin Hydorchloride
3. Inverness Medical Innovations, Inc. Announces Offering of $150 Million of Senior Notes
4. Crisco(R) Announces the Crisco Live Smart, Cook Smarter Contest Winners
5. CCHRINT Announces FDA Reported Psychiatric Drug Side Effects Search Engine
6. Samarion Announces Partnership With Adesta to Install the SamarionSolution Nationwide
7. EPIX Pharmaceuticals, Inc. Announces August 25, 2009 for the Auction Sale of Equipment and September 30, 2009 for the Auction Sale of the Intellectual Property
8. Ferring Pharmaceuticals Announces Trade Name FIRMAGON(R) (degarelix for injection) for Advanced Prostate Cancer Treatment
9. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
10. Presidents Council Announces Top 5 Winners of 2009 National Presidents Challenge
11. Arcadia Resources Announces Webcast of Its Fiscal 2010 First Quarter Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)... "The YogaForce A-Line Athletic Mat is grea... Weil, M.D., author and physician best known for e...ive medicine. Go to www.yogaforce.com and order...ift list. , San Francisco... the holidays, the YogaForce newly patented, revol...
(Date:11/28/2009)...Nov. 28 Get ready for advanced ...nical routine when Siemens introduces syngo...nnual Meeting of the Radiological Society of North...McCormick Place (Booth #825, East Building/Lakesid... , Siemens, new imaging software for multimodal...
(Date:11/28/2009)...elp lift spirits, recognize signs of depression ,...For many seniors, the holiday season can trigger m...uggle with health issues or worry about money prob.... , To help overcome the seasonal blues, the AG...ing advice: , Get out and socialize or invite fa...
(Date:11/27/2009)... Biotech firm Replikins Ltd. today issued its la...c data. It shows that the lethality of the virus ... the virus,s current outbreak in the spring of 200...(s.d. 0.1). The H1N1 infectivity count, however, r...n (PRWEB) November 27, 2009 -- Biotech firm Replik...
(Date:11/27/2009)...N.Y., Nov. 27 Preventin...r and fortunately every year, new vaccines are bei...ll vaccines boost immunity for the same period of ...ots, needed to keep immunity strong? ,, In th... American Academy of Pediatrics, Michael Pichicher...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3
...nsion journal suggests that increasing, dietary ...revention of hypertension, a major pu...e good sources of potassium and low in sodium ...Hypertension,concludes that an increase in potassi...
...olecular "smart bombs" to target metastasis with a...ficantly lower doses of toxic chemotherapy, with l...ding to a collaborative team of researchers at the...ector of Translational Research David Cheresh, Ph....
...ty HealthSystem,Consortium (UHC), welcomes Susan K...Chief Learning Officer. Dr. Pingleton has more tha...cine and comes to UHC from The,University of Kansa... Scholar in Residence at the Association of,Americ...
...sk for psychiatric disorders, study finds , ...lone isn,t associated with an increased risk of me...en suggested that pregnant women and those who,ve ...he study. , To determine whether this was true, th...
... trusted and,accessible health care providers, pha... and make more than 80 million recommendations to ...tients will follow these,recommendations. In fact,... purchase a particular OTC medicine based on,their...
...ny,(Nasdaq: PRGO ;TASE) announced today that Jose...t at the Oppenheimer & Co. Inc. 8th Annual Consume...m. (ET) at the Four Seasons,Hotel in Boston. The p...l healthcare supplier that develops,manufactures a...
Other Medicine News:Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 2Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 3Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 4Health News:Unilever Unveils Promise(R) SuperShots(R) for Blood Pressure, the First Functional Shot to Increase Daily Potassium Intake to Help Reduce the Risk of High Blood Pressure 5Health News:'Smart bomb' nanoparticle strategy impacts metastasis 2Health News:University HealthSystem Consortium Names Susan K. Pingleton, MD, as Its Chief Learning Officer 2Health News:Pregnancy Alone Not A Risk for Mental Health Problems 2
(Date:11/25/2009)..., HARBIN, China, Nov. 25 /PRNewswire-Asia-F...ky One Medical" or "the Company") (Nasdaq: CSKI )...y developing and producing,over-the-counter drugs ...nnounced that the Company recently passed the Chin...utical and Biological Products ("ICPBP") examinati...
(Date:11/25/2009)..., EAST BRUNSWICK, N.J., Nov. 25 S... of direct digital Radiography ( ddR ) systems, an...ed by a private Swiss Investor with a long term vi...d. The acquisition included all assets and intelle.... After 25 years of success and growth Swissray is...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Reportlink... is available in its catalogue: ,, Pain Manag...nker.com/p0164220/Pain-Management---Global-Trends....gs, emergence of pain management clinics, and the ...rowth in the pain management market. Healthcare re...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Swissray International Announces New Ownership 2Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 1Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 2Research identifies successful new treatment for Hodgkins lymphoma reduces long term risks 51529 3Herbicide diversity needed to keep Roundup effective 9243 1Herbicide diversity needed to keep Roundup effective 9243 2Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 1Hoag Hospital Breast Care Center Recognized as a Certified Quality Breast Center 51526 2
...d Community Oncology Research Network, Inc. Surpas...MEMPHIS, Tenn., March 31 The Accelerated Communit...nal oncology clinical trial,network, announced tod...xceeded performance expectations over the past 12 ...earch services to sponsors, from clinical,trial de...
... of Target Enrollment Expected in Fourth Quarter, ...ted (Nasdaq: GNTA ) announced that the Data Safet...ial of Genasense (oblimersen sodium),Injection, wh...commended,that the trial be continued as originall...ata from the study., AGENDA is a Phase 3, randomi...
Other Medicine Technology:ACORN's Oncology-focused Contract Research Organization Exceeds Projections 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 2DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 3DSMB Supports Continuation of Phase 3 AGENDA Trial of Genasense(R) in Advanced Melanoma 4
SureStep LH
Clearview Exact Strep A Dipstick
Clearview Exact Strep A Cassette
Inverness Medical Testpack+Plus Strep A with OBC (20 Tests)
Medicine Products: